[HTML][HTML] Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and …
T Wang, Z Zhou, X Wang, L You, W Li, C Zheng… - Frontiers in …, 2022 - frontiersin.org
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
[HTML][HTML] Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and …
T Wang, Z Zhou, X Wang, L You, W Li, C Zheng… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental …
T Wang, Z Zhou, X Wang, L You, W Li, C Zheng… - Frontiers in …, 2022 - europepmc.org
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental …
T Wang, Z Zhou, X Wang, L You, W Li… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental …
T Wang, Z Zhou, X Wang, L You, W Li… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …